Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950123-11-040375
Filing Date
2011-04-28
Accepted
2011-04-28 06:01:55
Documents
1
Group Members
JOSHUA SILVERMANRICHARD ABBE

Document Format Files

Seq Description Document Type Size
1 SC 13G c64383sc13g.htm SC 13G 52902
  Complete submission text file 0000950123-11-040375.txt   54617
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Subject) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-51477 | Film No.: 11785415
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022
Business Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022 212.974.3070
Iroquois Capital Management, LLC (Filed by) CIK: 0001481867 (see all company filings)

EIN.: 010786483
Type: SC 13G